Literature DB >> 16341809

Linkage of a pedigree drawing program and database to a program for determining BRCA mutation carrier probability.

Sharon R Sand1, David S DeRam, Deborah J MacDonald, Kathleen R Blazer, Jeffrey N Weitzel.   

Abstract

An export module was developed for transferring primary relational pedigree data directly from a widely used pedigree program and relational database to the BRCAPRO program for calculation of BRCA gene mutation probability estimation.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16341809     DOI： 10.1007/s10689-005-8849-y

Source DB:  PubMed          Journal:  Fam Cancer        ISSN： 1389-9600            Impact factor:   2.375


  12 in total

1.  A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO.

Authors:  D G R Evans; D M Eccles; N Rahman; K Young; M Bulman; E Amir; A Shenton; A Howell; F Lalloo
Journal:  J Med Genet       Date:  2004-06       Impact factor: 6.318

Review 2.  Genetic cancer risk assessment. Putting it all together.

Authors:  J N Weitzel
Journal:  Cancer       Date:  1999-12-01       Impact factor: 6.860

3.  Linkage of a pedigree drawing program and database to a program for determining BRCA mutation carrier probability.

Authors:  Sharon R Sand; David S DeRam; Deborah J MacDonald; Kathleen R Blazer; Jeffrey N Weitzel
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

4.  BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.

Authors:  F J Couch; M L DeShano; M A Blackwood; K Calzone; J Stopfer; L Campeau; A Ganguly; T Rebbeck; B L Weber
Journal:  N Engl J Med       Date:  1997-05-15       Impact factor: 91.245

5.  BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.

Authors:  Donald A Berry; Edwin S Iversen; Daniel F Gudbjartsson; Elaine H Hiller; Judy E Garber; Beth N Peshkin; Caryn Lerman; Patrice Watson; Henry T Lynch; Susan G Hilsenbeck; Wendy S Rubinstein; Kevin S Hughes; Giovanni Parmigiani
Journal:  J Clin Oncol       Date:  2002-06-01       Impact factor: 44.544

6.  Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2.

Authors:  G Parmigiani; D Berry; O Aguilar
Journal:  Am J Hum Genet       Date:  1998-01       Impact factor: 11.025

Review 7.  Application of breast cancer risk prediction models in clinical practice.

Authors:  Susan M Domchek; Andrea Eisen; Kathleen Calzone; Jill Stopfer; Anne Blackwood; Barbara L Weber
Journal:  J Clin Oncol       Date:  2003-02-15       Impact factor: 44.544

8.  Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.

Authors:  Thomas S Frank; Amie M Deffenbaugh; Julia E Reid; Mark Hulick; Brian E Ward; Beth Lingenfelter; Kathi L Gumpper; Thomas Scholl; Sean V Tavtigian; Dmitry R Pruss; Gregory C Critchfield
Journal:  J Clin Oncol       Date:  2002-03-15       Impact factor: 44.544

9.  American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

Authors: 
Journal:  J Clin Oncol       Date:  2003-04-11       Impact factor: 44.544

10.  The BOADICEA model of genetic susceptibility to breast and ovarian cancer.

Authors:  A C Antoniou; P P D Pharoah; P Smith; D F Easton
Journal:  Br J Cancer       Date:  2004-10-18       Impact factor: 7.640
View more
  3 in total

1.  Linkage of a pedigree drawing program and database to a program for determining BRCA mutation carrier probability.

Authors:  Sharon R Sand; David S DeRam; Deborah J MacDonald; Kathleen R Blazer; Jeffrey N Weitzel
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 2.  Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.

Authors:  Jeffrey N Weitzel; Kathleen R Blazer; Deborah J MacDonald; Julie O Culver; Kenneth Offit
Journal:  CA Cancer J Clin       Date:  2011-08-19       Impact factor: 508.702

3.  Double heterozygous pathogenic variants prevalence in a cohort of patients with hereditary breast cancer.

Authors:  Thais Baccili Cury Megid; Mateus C Barros-Filho; Janina Pontes Pisani; Maria Isabel Achatz
Journal:  Front Oncol       Date:  2022-08-08       Impact factor: 5.738
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.